Details for New Drug Application (NDA): 090642
✉ Email this page to a colleague
The generic ingredient in VALSARTAN is hydrochlorothiazide; valsartan. There are thirty-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; valsartan profile page.
Summary for 090642
Tradename: | VALSARTAN |
Applicant: | Watson Labs Inc |
Ingredient: | valsartan |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 090642
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Jan 5, 2015 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Jan 5, 2015 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 160MG | ||||
Approval Date: | Jan 5, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription